CAS: 529-35-1; 5,6,7,8-Tetrahydro-1-Naphthol

该化合物是一种部分氢化的氯化萘衍生物,配有分子式C10H12O.该化合物的特征是附属于四氢-甲苯环系统的氢氧基组,使其在有机合成中成为多功能中间体.其部分饱和结构增强了稳定性,同时保持了进一步功能化的再活动,如氧化或替代反应.该化合物在制药和农用化学应用中特别有用,因为它是合成生物活性分子的前体.其平衡的亲脂性和中度极性促进了普通有机溶剂的溶性,确保了在实验室和工业环境中处理的方便性.建议在惰性条件下妥善储存以保持纯度.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号90-15-3 1-萘酚 | CAS号21336-06-1 Cyclohexene, 1,... | CAS号119-64-2 1,2,3,4-四氢萘(THN) | CAS号89228-42-2 4-羟基-5,6,7,8-四氢... | CAS号85531-80-2 2-氧代-5,6,7,8-四氢... | CAS号1125-78-6 5,6,7,8-四氢-2-萘酚 | CAS号108-94-1 环己酮 | CAS号78677-75-5 syn-2,5-Epidiox... | CAS号10465-20-0 1-Naphthalenebu... | CAS号1008-19-1 5-甲氧基-1,2,3,4-四氢萘 | CAS号107203-39-4 2-prop-2-enyl-5... | CAS号107203-35-0 allyl-(5,6,7,8-... | CAS号861094-58-8 allyl-(2-allyl-... | CAS号493-01-6 萘烷 | CAS号493-02-7 反-十氢化萘 | CAS号91-17-8 十氢萘 | CAS号76928-35-3 5,6,7,8-tetrahy... | CAS号628-13-7 吡啶盐酸盐

合成工艺路线路线简述

    萘酚置于palladium On Activated Charcoal,氢气体系中,用 乙醇 作为反应溶剂,50.0 °C,8.11 Mpa 条件下,反应 8.0H,以95%的收率获得产物四氢萘酚
    参考文献:H 4-萘衍生的轴向手性联芳基吡ido胺对α-酮酸的对映选择性仿生氨基转移
    标题:H 4-萘衍生的轴向手性联芳基吡ido胺对α-酮酸的对映选择性仿生氨基转移
    摘要:不对称仿生转氨反应是合成化学和生物学上重要的手性氨基酸和手性胺的极具吸引力的方法.手性吡ido胺/吡rid醛的开发是反应的关键.已经开发了基于h 4-萘基骨架的新的轴向手性联芳基吡ido胺.吡ido胺在α-酮酸的不对称仿生转氨反应中表现出非常好的对映选择性和高催化活性,可提供多种旋光性非天然氨基酸,产率为61-98%,Ee可达91%.
    DOI:10.1016/j.Tetlet.2018.01.089

    海关参考信息

    专利信息


    专利号:US-10040752-B2
    优先权日:2015-08-24
    标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
    发明人:MKRTCHYAN GNEL; YAO QINGWEI
    权利人:CODY LABORATORIES INC
    摘要:Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are provided comprising administering a composition comprising an effective amount of levomethadone hydrochloride having not more than 10 ppm dextromethadone.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-4758661-A
    优先权日:1986-06-24
    标题 :Chiral synthesis of (+)-trans-1a,2,3,4a,5,6-hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-oxazine
    发明人:MELILLO DAVID G; MATHRE DAVID J; LARSEN ROBERT D
    权利人:MERCK & CO INC
    摘要:(+)-trans-1a,2,3,4a,5,6-Hexahydro-9-hydroxy-4-propyl-4H-naphth[1,2-b]-1,4-oxazine is elaborated by a series of process steps that retain the enantiomeric purity of the starting material, D-aspartic acid. The product is a direct acting dopaminergic agent, useful in the treatment of Parkinson's disease.

    专利号:WO-2023122754-A1
    优先权日:2021-12-23
    标 题 :Processes and intermediates for preparing gb13, gb22 and himgaline
    发明人:LANDWEHR ELEANOR; SHENVI RYAN; BAKER MEGHAN; OGUMA TAKUYA
    权利人:SCRIPPS RESEARCH INST
    摘要:Provided herein are processes for the streamlined synthesis of Galbulimima alkaloids, such as himbadine, isolated from Galbulimima belgraveana and G. baccatta, trees endemic to the rainforests of Northern Australia and Papua New Guinea, as well as analogs thereof, such as GB13, GB16, GB22, and himgaline, and further including intermediates useful in the synthesis of these and related compounds.

    专利号:US-2019002394-A1
    优先权日:2015-08-24
    标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof

    专利号:US-2017057909-A1
    优先权日:2015-08-24
    标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
    安庆博曼生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bomanbiochem.com
    企业联系电话:0556-5203536👤
    📞安庆博曼生物技术有限公司 ⚠️参考联系方式
    联系人:陈 佳(总经理) 何雪垠(技术总监)
    电话:0556-5203536
    手机:13588048971;18955636051/13365798276
    传真:0556-5203536
    邮箱:sales@bomanbiochem.com;chen@bomanbiochem.com
    通信地址: 安徽省安庆市高新区皇冠路8号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省安庆市高新区皇冠路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Barsegyan, Y. A.; Vil’, V. A.; Tomkinson, N. C. O.; Terent’ev, A. O., Science of Synthesis Knowledge Updates, (2022) 1, 239.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知